Medications for opioid use disorder during pregnancy: Access and continuity in a state women’s prison facility, 2016-2019

Original research
par
Knittel, AK et al

Date de publication

2022

Géographie

USA

Langue de la ressource

English

Texte disponible en version intégrale

Non

Open Access / OK to Reproduce

Non

Évalué par des pairs

Yes

L’objectif

Although medications to treat opioid use disorder (MOUD) are the standard of care during pregnancy, there are many potential gaps in the cascade of care for pregnant people experiencing incarceration.

Constatations/points à retenir

Only 40% of eligible pregnant people with opioid use disorder received either buprenorphine or methadone during incarceration. Fewer than one-third were referred for medications for opioid use disorder when they returned to the community after incarceration. Withdrawal symptoms are common among people whose buprenorphine or methadone are discontinued immediately postpartum during incarceration.

La conception ou méthodologie de recherche

Retrospective cohort study of pregnant people with opioid use disorder incarcerated in a Southeastern women’s prison from 2016-2019

Mots clés

About PWUD
Legal system/law enforcement
Substitution/OAT